FDA aims to limit Expiration of pre-filled Avastin to 5 days

Dear Physician,   As you may be aware, recently, draft FDA guidance documents were released that provide the framework for how the agency intends on enforcing the Drug Quality and Securities Act (DQSA).   Addressed in these documents was the repackaging of certain human drugs.  Of particular concern is the agency’s intended limitations on repackaging… Read more »

Pine Pharmaceuticals participating in ASRS Practice Management Issues Seminar

Next month Pine Pharmaceuticals will be participating in the 17th Annual ASRS Practice Management Issues Seminar in Dallas, Texas.  The seminar is scheduled to take place March 27th – 29th at the Hyatt Regency Hotel.   This popular seminar is designed for retinal physicians and administrators of vitreoretinal practices to learn the business principles necessary to… Read more »